Episode Details

Scientists at McMaster University have discovered a potential game-changer in cancer treatment: a new class of drugs targeting IMPDH2, an enzyme cancers use to spread to the brain. With brain metastases currently untreatable beyond symptom management and radiation that damages healthy tissue, this targeted approach could prevent deadly spread without harming the brain. Still in early stages, the team aims to develop a daily pill for cancer survivors to stop recurrence in the brain — offering hope where there was once little.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/325d5e5e0aef5768